Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Anna Rosén

Anna Rosén

Forskare och överläkare. Leder DIRECT-studien som syftar till att förbättra information till personer med ärftligt ökad risk för cancer. 

Kontakt

E-post
anna.rosen@umu.se
Telefon
072-453 48 09

Verksam vid

Anknytning
Anknuten som läkare till Institutionen för strålningsvetenskaper Enhet: Onkologi
Plats
Målpunkt P01. Regionalt Cancercentrum (RCC), Norrlands universitetssjukhus, Ledningsstaben VLL Umeå universitet, 901 87 Umeå

Anna Rosén arbetar som överläkare vid cancergenetiska mottagningen. Hon leder multicenterstudien DIRECT, som syftar till att utforma och utvärdera nya metoder att informera individer med ärftligt förhöjd risk att drabbas av cancer. 

Cancer Worry Distribution and Willingness to Undergo Colonoscopy at Three Levels of Hypothetical Cancer Risk - A Population-Based Survey in Sweden
Cancers, MDPI 2022, Vol. 14, (4)
Hawranek, Carolina; Maxon, Johan; Andersson, Andreas; et al.
Whole-Body MRI Surveillance: Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)
Cancers, MDPI 2022, Vol. 14, (2)
Omran, Meis; Tham, Emma; Brandberg, Yvonne; et al.
Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden
BMJ Open, BMJ Publishing Group Ltd 2022, Vol. 12, (6)
Rosén, Anna; Otten, Julia; Stomby, Andreas; et al.
Healthcare professionals' responsibility for informing relatives at risk of hereditary disease
Journal of Medical Ethics, BMJ Publishing Group Ltd 2021, Vol. 47, (12)
Grill, Kalle; Rosén, Anna
A Focus Group Study of Perceptions of Genetic Risk Disclosure in Members of the Public in Sweden: "I’ll Phone the Five Closest Ones, but What Happens to the Other Ten?"
Journal of Personalized Medicine, MDPI 2021, Vol. 11, (11)
Hawranek, Carolina; Hajdarevic, Senada; Rosén, Anna
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden
Hereditary Cancer in Clinical Practice, Springer Nature 2020, Vol. 18
Andersson, Andreas; Hawranek, Carolina; Öfverholm, Anna; et al.
Cancer worry and willingness to undergo colonoscopy at different risk levels: results from a population-based survey in Sweden
European Journal of Human Genetics, Springer Nature 2020, Vol. 28 : 786-786
Hawranek, Carolina; Maxon, J.; Andersson, Andreas; et al.
Prophylactic Mastectomy: Postoperative Skin Flap Thickness Evaluated by MRT, Ultrasound and Clinical Examination
Annals of Surgical Oncology, Springer Nature 2020, Vol. 27 : 2221-2228
Wiberg, Rebecca; Andersson, Magnus N.; Svensson, Johan; et al.
The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden
Familial Cancer, Springer 2019, Vol. 18, (1) : 37-42
Edwinsdotter Ardnor, Christina; Rosén, Anna; Ljuslinder, Ingrid; et al.
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders
European Journal of Human Genetics, Nature Publishing Group 2018, Vol. 26, (6) : 858-867
Norberg, Anna; Rosén, Anna; Raaschou-Jensen, Klas; et al.
Role of HLA-DQ Genotyping in Celiac Disease
Journal of Pediatric Gastroenterology and Nutrition - JPGN, Vol. 62, (3) : E30-E31
Sandström, Olof; Rosén, Anna; Ivarsson, Anneli
Role of HLA-DQ Genotyping in Celiac Disease
Journal of Pediatric Gastroenterology and Nutrition - JPGN, Vol. 62, (3) : E30-E31
Sandström, Olof; Rosén, Anna; Ivarsson, Anneli
High adherence to a gluten-free diet in adolescents with screening-detected celiac disease
Journal of Pediatric Gastroenterology and Nutrition - JPGN, Lippincott Williams & Wilkins 2015, Vol. 60, (1) : 54-59
Webb, Charlotta; Myléus, Anna; Norström, Fredrik; et al.
Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening
Journal of Pediatric Gastroenterology and Nutrition - JPGN, Lippincott Williams & Wilkins 2015, Vol. 60, (6) : 787-791
Webb, Charlotta; Norström, Fredrik; Myléus, Anna; et al.
Internalizing the threat of risk: a qualitative study about adolescents' experience living with screening-detected celiac disease 5 years after diagnosis
Health and Quality of Life Outcomes, BioMed Central 2014, Vol. 12
Nordyke, Katrina; Rosén, Anna; Emmelin, Maria; et al.
Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants
Gut, Vol. 63, (3) : 415-422
Romanos, Jihane; Rosén, Anna; Kumar, Vinod; et al.
Usefulness of symptoms to screen for celiac disease
Pediatrics, Vol. 133, (2) : 211-218
Rosén, Anna; Sandström, Olof; Carlsson, Annelie; et al.
Body mass index is not a reliable tool in predicting celiac disease in children
BMC Pediatrics, BioMed Central 2014, Vol. 14 : 165-
van der Pals, Maria; Myléus, Anna; Norström, Fredrik; et al.
Prevalence of childhood celiac disease and changes in infant feeding
Pediatrics, Vol. 131, (3) : e687-e694
Ivarsson, Anneli; Myléus, Anna; Norström, Fredrik; et al.
Health-related quality of life in adolescents with screening-detected celiac disease, before and one year after diagnosis and initiation of gluten-free diet, a prospective nested case-referent study
BMC Public Health, BioMed Central 2013, Vol. 13
Nordyke, Katrina; Norström, Fredrik; Lindholm, Lars; et al.
Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in a sequential testing
Journal of Pediatric Gastroenterology and Nutrition - JPGN, Lippincott Williams & Wilkins 2013, Vol. 57, (4) : 472-476
Sandström, Olof; Rosén, Anna; Lagerqvist, Carina; et al.
Mass screening for celiac disease in 12-year-olds: Finding them and then what?
Umeå University medical dissertations, 1520
Rosén, Anna
Mass screening for celiac disease from the perspective of newly diagnosed adolescents and their parents: A mixed-method study
BMC Public Health, BioMed Central 2011, Vol. 11 : 822-
Rosén, Anna; Emmelin, Maria; Carlsson, Annelie; et al.
Balancing health benefits and social sacrifices: a qualitative study of how screening-detected celiac disease impacts adolescents' quality of life
BMC Pediatrics, BioMed Central 2011, Vol. 11 : 32-
Rosén, Anna; Ivarsson, Anneli; Nordyke, Katrina; et al.
The preventCD study design: towards new strategies for the prevention of coeliac disease
European Journal of Gastroenterology and Hepathology, Vol. 22, (12) : 1424-1430
Hogen Esch, Caroline Elisabeth; Rosén, Anna; Auricchio, Renata; et al.
Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic
Journal of Pediatric Gastroenterology and Nutrition - JPGN, New York: Raven P 2009, Vol. 49, (2) : 170-176
Myléus, Anna; Ivarsson, Anneli; Webb, Charlotta; et al.
Reduced prevalence of childhood celiac disease: an effect of changes in infant feeding?
Ivarsson, Anneli; Myléus, Anna; Norström, Fredrik; et al.
Symptoms do not predict celiac disease in a mass screening of Swedish 12-year-olds
Rosén, Anna; Sandström, Olof; Carlsson, Annelie; et al.
Visa publikationer i DiVA

Forskningsprojekt

2 september 2019 till 30 november 2023
DIRECT-studien - Genetisk riskinfo för att förebygga cancer

Undervisar på läkarprogrammet, biomedicinarprogrammet, specialistutbildning för onkologisjuksköterskor, samt vid fortbildning för AT-och ST-läkare. 

Ämnen:

  • prevention
  • folkhälsoarbete
  • screening
  • klinisk genetik
  • ärftlig cancer
  • etik och genetik
  • forskningsmetodik
  • kvalitativ forskningsmetodik
  • epidemiologi